Quanterix Corp QTRX.OQ reported a quarterly adjusted loss of 57 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -25 cents. The mean expectation of four analysts for the quarter was for a loss of 36 cents per share. Wall Street expected results to range from -41 cents to -30 cents per share.
Revenue fell 28.8% to $24.48 million from a year ago; analysts expected $28.23 million.
Quanterix Corp's reported EPS for the quarter was a loss of 77 cents.
The company reported a quarterly loss of $30.01 million.
Quanterix Corp shares had fallen by 17.1% this quarter and lost 48.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 11.8% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Quanterix Corp is $8.00, about 31.1% above its last closing price of $5.51
This summary was machine generated from LSEG data August 8 at 05:30 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | -0.36 | -0.57 | Missed |
Mar. 31 2025 | -0.44 | -0.42 | Beat |
Dec. 31 2024 | -0.25 | -0.30 | Missed |
Sep. 30 2024 | -0.24 | -0.22 | Beat |